Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Oct 27, 2023 1:32pm
ATE
Much less pressure. Market By Price Price Total Volume Value 0.750 6,000 $4,500 0.740 2,500 $1,850
...more
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Comment by
Pronorvista
on Oct 26, 2023 12:57pm
RE:ATE
Market depth( ATS ) Market By Order Exchange Price Volume House Time CX2 0.690 4,000 Anonymous 11:48
...more
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Oct 26, 2023 12:03pm
ATE
Next step 0,70-0,80 Market By Price Price Total Volume Value 0.750 6,000 $4,500 0.740 2,500 $1,850
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 24, 2023 2:21pm
Next Catalyst 🚀
less than 3 weeks away, an update with the financials report, that i think will include a statement from management saying that everything is still on schdule for P2 in Q1 2024. big signal to
...more
(5)
•••
Mmmtroll
X
View Profile
View Bullboard History
Post by
Mmmtroll
on Oct 20, 2023 4:51pm
Chronic back on the menu?
Dumpster I still want those shares at 80c where you at
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 20, 2023 3:11pm
davgro👉😕⩋⩋⩋⩋⩋⩋⩋⩋⩋⩋⩋ the ss ATE👉⩋⩋⩋⩋⩋ ⛵🌞
it is clear skies and calm waters ahead, i think we get to the 80 cent range next month prior to the financials report. lol
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 20, 2023 12:28pm
It Is Too Bad
my good friend davgro got left standing on the dock with his pants down while the good ship ATE steamed away. "clearly below in his post he got some bad advice and decided to push his own
...more
(218)
•••
baggerx99
X
View Profile
View Bullboard History
Comment by
baggerx99
on Oct 20, 2023 11:54am
RE:RE:ATE
A multi million share volume day will really accelerate the sp.....some additional good news will do wonders. I believe watchers are very comfortable with how things are progressing, seems all ducks
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 19, 2023 2:17pm
Still ridiculously undervalued
6 weeks ago ATE was @60 cents. and the recent drop to the mid 40's was just nuts.
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on Oct 19, 2023 2:04pm
RE:ATE
Good news plus added volume and we may start to get somewhere...
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Oct 19, 2023 12:58pm
ATE
Finally life in ate probably good news in the short term
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 19, 2023 12:27pm
The tide is turning
23K just sold over half of it @ 52 cents
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 18, 2023 9:33am
Black Out Periods
Black-Out Periods There is a mandatory 2 week blackout period for all employees of a Company prior to the release of quarterly and annual financial statements which shall continue until two trading
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Oct 18, 2023 9:23am
My guess
is we will find out the PK/PD data mid november with the Q2 financials. may or may not see insider buying as they will likely be in blackout when they find out the data results, "unless the data
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 18, 2023 7:02am
New Press Release - Antibe Initiates First Clinical Study of Otenaproxesul's New Formulation
- Data in November will inform Phase II trial expected to launch next quarter Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation therapies targeting pain and inflammation, is pleased to announce the...
read article.
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >